Document ID: chunk:federal_register_of_legislation:F2024C01228:front:0:p4
Version: federal_register_of_legislation:F2024C01228
Segment Type: other
Provision Reference: 
Character Range: 7612–10582

about 6 months of age and has one or more of the following medical risk conditions:
 (A) functional or anatomical asplenia including sickle cell disease, other haemoglobinopathies, congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; or
 (B) immunocompromising conditions including congenital or acquired immune deficiency including symptomatic IgG subclass or isolated IgA deficiency, haematological malignancies, solid organ transplant haematopoietic stem cell transplant (HSCT) or HIV infection; or
 (C) chronic respiratory disease including suppurative lung disease, bronchiectasis and cystic fibrosis or chronic lung disease of prematurity; or
 (D) chronic renal disease including: end stage renal disease –  eGFR <15mL/min or relapsing or persistent nephrotic syndrome; or
 (E) proven or presumptive cerebrospinal fluid (CSF) leak; or
 (F) cochlear implants; or
 (G) intracranial shunts; or
 (H) previous episode of invasive pneumococcal disease (IPD); or
 (I) born less than 28 weeks gestation; or
 (J) trisomy 21; or
 (K) chronic heart disease including cyanotic heart disease and heart failure;
 (ii) who is at least 12 months and less than 5 years of age and has been newly diagnosed with one or more of the medical risk conditions contained in subparagraph (b)(i);
 (iii) who is at least 5 years of age and has been newly diagnosed with one or more of the medical risk conditions contained in subparagraphs (b)(i)(A)‑(H);
 (c) a dose of the vaccine may be provided to a person:
 (i) who is an Aboriginal and/or Torres Strait Islander; and
 (ii) who is at least 50 years.
 (d) a dose of the vaccine may be provided to a person:
 (i) who is not an Aboriginal and/or Torres Strait Islander; and
 (ii) who is at least 70 years.
 (2) For item 112 of Schedule 1, a designated vaccine in that item may be provided in the following circumstances:
 (a) a first dose of the vaccine may be provided to a person:
 (i) who is at least 4 years but less than 6 years and has one or more of the following medical risk conditions:
 (A) functional or anatomical asplenia including sickle cell disease or other haemoglobinopathies, congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; or
 (B) immunocompromising conditions including congenital or acquired immune deficiency including symptomatic IgG subclass or isolated IgA deficiency, haematological malignancies, solid organ transplant haematopoietic stem cell transplant (HSCT) or HIV infection; or
 (C) chronic respiratory disease including suppurative lung disease, bronchiectasis and cystic fibrosis or chronic lung disease of prematurity; or
 (D) chronic renal disease including end stage renal disease –  eGFR <15mL/min, relapsing or persistent nephrotic syndrome; or
 (E) proven or presumptive cerebrospinal fluid (CSF) leak; or
 (F) cochlear implants; or
 (G) intracranial shunts; or
 (H)  previous episode of invasive pneumococcal disease (IPD); or
 (I) born less than 28 weeks gestation;